GNH USA

Europe — EMA

Magnesiocard Retard

GNH USA supplies Magnesiocard Retard (Magnesium Aspartate Hydrochloride), a magnesium supplement for deficiency and related muscle‑cramp conditions.

Magnesium Aspartate Hydrochloride

Request sourcing

1
Pack/s

What is Magnesium Aspartate Hydrochloride?

Magnesium Aspartate Hydrochloride, the active ingredient in Magnesiocard Retard, is a magnesium salt presented as a retard (extended‑release) oral formulation for oral use. It provides magnesium supplementation and may support normal muscle and nerve function in adults.\n\nGNH India supplies Magnesiocard Retard as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals, pharmacies and clinics worldwide.

What is Magnesium Aspartate Hydrochloride used for?

Magnesiocard Retard is used to address conditions related to low magnesium levels.\n\n- Magnesium deficiency: helps restore normal serum magnesium concentrations.\n- Hypomagnesemia: supports correction of clinically low magnesium in patients.\n- Muscle cramps: may reduce the frequency of cramps associated with inadequate magnesium status.

What are the side effects of Magnesium Aspartate Hydrochloride?

Magnesiocard Retard may cause a range of adverse reactions.\n\nCommon Side Effects:\n- Diarrhoea: loose stools occurring after oral intake.\n- Abdominal discomfort: cramping or pain in the stomach region.\n- Nausea: feeling of sickness or urge to vomit.\n- Flatulence: excess gas in the gastrointestinal tract.\n- Metallic taste: transient alteration of taste perception.\n- Headache: mild to moderate head pain.\n\nSerious or Rare Side Effects:\n- Hypermagnesemia: elevated blood magnesium leading to cardiac arrhythmia or hypotension.\n- Severe allergic reaction: rash, swelling, or anaphylaxis.\n- Respiratory depression: slowed breathing in extreme excess.\n- Muscle weakness: notable reduction in muscle strength.\n- Cardiac conduction abnormalities: changes in heart rhythm.\n- Kidney failure exacerbation: worsening renal function due to magnesium accumulation.

What precautions apply to Magnesium Aspartate Hydrochloride?

When prescribing Magnesiocard Retard, clinicians should consider several safety measures.\n\n- Baseline assessment: check serum magnesium before initiating therapy.\n- Renal impairment: adjust dose or avoid use in patients with reduced kidney function.\n- Monitor for hypermagnesemia: watch for flushing, low blood pressure, or cardiac changes.\n- Concomitant supplements: avoid simultaneous high‑dose magnesium products.\n- Pregnancy and lactation: use only if clearly indicated after risk‑benefit evaluation.\n- Store at room temperature: keep in the original container, protect from moisture.

What does Magnesium Aspartate Hydrochloride interact with?

Magnesiocard Retard can interact with several medicines, requiring caution.\n\nMajor Interactions (Avoid):\n- Calcium channel blockers: increased risk of hypermagnesemia.\n- Aminoglycoside antibiotics: magnesium may reduce antibacterial efficacy.\n- Bisphosphonates: concurrent use can impair absorption of both agents.\n\nModerate Interactions (Monitor Closely):\n- Loop and thiazide diuretics: may alter magnesium balance.\n- Proton pump inhibitors: potential reduction in magnesium absorption over long term.\n- Oral iron supplements: decreased magnesium uptake when taken together.

Frequently asked questions

What is Magnesiocard Retard used for?+
Magnesiocard Retard is an oral magnesium supplement used to correct magnesium deficiency, treat clinically low magnesium (hypomagnesemia), and help reduce muscle cramps that can occur when magnesium levels are insufficient.
How does Magnesium Aspartate Hydrochloride work?+
The compound dissociates after ingestion, releasing magnesium ions that act as essential cofactors for many enzymatic reactions, stabilize ATP, and modulate calcium channels, thereby supporting normal nerve, muscle, and cardiac function.
What is the usual dose of Magnesiocard Retard?+
The dose of Magnesiocard Retard is determined by the prescribing clinician based on the patient’s serum magnesium level, age, renal function, and clinical indication. No fixed regimen is provided here.
Is Magnesiocard Retard safe during pregnancy or breastfeeding?+
Magnesiocard Retard should be used in pregnancy or while breastfeeding only if the potential benefit justifies any possible risk to the fetus or infant. The decision must be made by a qualified health professional.
How do I order Magnesiocard Retard from GNH USA?+
To order, submit an enquiry on the product page at gnh-usa.com specifying the required quantity. GNH USA works with hospitals, pharmacies and procurement teams worldwide, verifies trade or institutional credentials, and then provides pricing, availability, shipping details and any necessary import documentation.
How does Magnesiocard Retard compare with other magnesium supplements?+
Magnesiocard Retard provides magnesium in the aspartate salt form with an extended‑release profile, which may offer more gradual absorption compared with immediate‑release magnesium oxide or citrate. This can reduce gastrointestinal upset while still delivering therapeutic magnesium levels.
How should Magnesiocard Retard be stored and handled?+
Store Magnesiocard Retard at room temperature, below 25 °C, in its original packaging. Keep the container tightly closed and protect it from moisture and direct sunlight to maintain product stability.
How is Magnesiocard Retard administered?+
Magnesiocard Retard is taken orally, usually with a full glass of water. It is formulated for extended release, so it should be swallowed whole and not crushed or chewed to preserve its intended absorption profile.
What are the most serious risks associated with Magnesiocard Retard?+
The most serious risks include hypermagnesemia, which can cause cardiac arrhythmias, severe hypotension, respiratory depression, and muscle weakness. Prompt medical attention is required if symptoms of excess magnesium appear.
Who should not use Magnesiocard Retard?+
Patients with severe renal impairment, known hypersensitivity to magnesium salts, or those already receiving high‑dose magnesium therapy should avoid Magnesiocard Retard unless a healthcare professional advises otherwise.
Information provided on this page is for educational use by procurement and clinical professionals. Always consult a licensed healthcare provider for medical advice and prescribing decisions. GNH USA supplies this product subject to applicable regulatory and licensing requirements.

Product details

Drug
Magnesium Aspartate Hydrochloride
Route
Oral Use
Manufacturer
Verla-Pharm Arzneimittel Gmbh & Co. Kg
Origin
EU

Related products